SCHEMBL6801536

SCHEMBL6801536

CC1(N=C(N)NS(=O)(=O)c2ccc(Cl)s2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 3/20 0.42
PSEN2 P49810 3/20 0.42
APH1B Q8WW43 3/20 0.42
NCSTN Q92542 3/20 0.42
APH1A Q96BI3 3/20 0.42
PSENEN Q9NZ42 3/20 0.42
MALT1 Q9UDY8 1/20 0.42
ALDH1A1 P00352 4/20 0.42
MAPT P10636 3/20 0.42
TDP1 Q9NUW8 1/20 0.42
HTR6 P50406 1/20 0.42
KMT2A Q03164 5/20 0.41
HTT P42858 2/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
FBP1 P09467 1/20 0.39
MEN1 O00255 2/20 0.39
TSHR P16473 1/20 0.39
CCR5 P51681 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6804437 0.77 HTR6 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3663503 0.74 MAPT (0.51) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6801528 0.72 ALDH1A1 (0.43) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3933822 0.71 FBP1 (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL682128 0.70 MAPT (0.63) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL22115699 0.70 CYP1A2 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL194745 0.69 MAPT (0.53) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL22089497 0.69 ALDH1A1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL264869 0.68 FBP1 (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL19341771 0.67 MAPT (0.51) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040010142-A1 Novel process NOVO NORDISK A/S (DK) 2004-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040010142-A1 Novel process UGT1A1, CYP4X1, CYP4B1 PSEN1 839/4885PSEN2 1915/4885APH1B 663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.